| 从供方角度探讨我国药品可及性问题 |
| |
| 引用本文： | 李海涛. 从供方角度探讨我国药品可及性问题[J]. 中国药物经济学, 2009, 0(5): 73-76 |
| |
| 作者姓名： | 李海涛 |
| |
| 作者单位： | 中国药科大学国际医药商学院,江苏南京,211198 |
| |
| 摘 要： | 本文主要从供方角度指出了影响药品可及性的因素。这些因素包括：到卫生服务机构的距离、市场的药品拥有程度,医疗机构的采购状况和医生的处方行为。卫生决策者应充分重视药品可及性问题,以促进我国人口健康状况的改善。
|
| 关 键 词： | 药品 可及性 公平 药品专利 诱导需求 |
Discussion on Issues of Drug Accessibility in China from Supply-side Perspective |
| |
| LI Haitao. Discussion on Issues of Drug Accessibility in China from Supply-side Perspective[J]. China Journal of Pharmaceutical Economics, 2009, 0(5): 73-76 |
| |
| Authors: | LI Haitao |
| |
| Affiliation: | LI Hai-tao (School of International Pharmaceutical Business of China Pharmaceutical University, Nanjing Jiangsu, 211198, China) |
| |
| Abstract: | The author of the paper, from supplier＇s perspective, mainly discusses the factors that will influence drug accessibility in China. The factors include the distance to health service facilities, drug patent system, drug approval system, drug profit and so on. Decision makers should pay much attention to drug accessibility, from which to promote improvement of health of residents in China. |
| |
| Keywords: | drug accessibility equity drug patent induced demand |
| 本文献已被 维普 万方数据 等数据库收录！ |
|
